twelve Bio

Twelve Bio is a gene-editing company that pioneers the therapeutic applications of next-generation CRISPR-Cas drugs and is also a developer of CRISPR-Cas12a diagnostic technology capable of detecting and altering any DNA sequence. CRISPR-Cas12a is an RNA-protein molecule that allows us to identify and modify specific DNA sequences. The RNA acts like a search engine to recognize specific DNA sequences, while the protein serves as molecular scissors to cut it.